A Study to Assess Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving 177Lu-DOTATATE
Latest Information Update: 18 May 2021
At a glance
- Drugs Lutetium-(177Lu)-oxodotreotide (Primary)
- Indications Peritoneal disorders
- Focus Adverse reactions
Most Recent Events
- 18 May 2021 New trial record